A New Treatment Option for Vestibular Migraine: Onabotulinum Toxin Type A

Journal Title: Istanbul Medical Journal - Year 2020, Vol 21, Issue 3

Abstract

Introduction: Vestibular migraine is a clinical entity characterised by dizziness. Additionally, it has no proven treatment options, and the goal is to control vestibular symptoms by reducing migraine attacks. This study aimed to investigate the effect of onabotulinum toxin type A in reducing vestibular migraine symptoms. Methods: Between 2014 and 2019, the charts of 80 patients with migraine who received onabotulinum toxin type A treatment were collected. Among them, 22 patients who met the criteria of vestibular migraine were included in the study. The treatment outcomes of these patients were investigated. Migraine Disability Assessment scale (MIDAS), Visual Analogue scale (VAS) and Dizziness Handicap index (DHI) were used for evaluation. Pre-treatment and post-treatment values were compared. Results: The mean age of the patients was 41.5 years. When MIDAS, DHI and VAS scores were compared, the post-treatment scores were found to be statistically significantly lower than the pre-treatment scores (p<0.05). Conclusion: Botulinum toxin treatment may be promising in patients with vestibular migraine. The limitation of this study is our relatively small group of patients. Therefore, there is a need for prospective work with a larger group of patients.

Authors and Affiliations

Reyhan Sürmeli, Tülay Erden Habeşoğlu

Keywords

Related Articles

Prediction of Prognostic Factors in the Survival of Non-small-cell Lung Cancer Patients with Multiple Brain Metastases

Introduction: We aimed to investigate the factors affecting survival in non-small-cell lung cancer (NSCLC) patients with multiple brain metastases. Methods: One hundred thirty patients who were diagnosed with NSCLC at t...

Radiotherapy in the Treatment of High Volume Chylous Fistula Following Hepatectomy: Case Report and Review of the Literature

Lymphatic injury is common in surgical procedures, but only 1-11% of cases present with chylous fistula. Although high volume chylous fistula is a rare condition after liver resection, serious life-threatening complicati...

Obesity Status of University Employees and Associated Factors: Turkey-2015

Introduction: Obesity is a growing public health concern with increasing prevalence in the world. It is aimed to investigate the relationship between socio-demographic features, dietary habits, physical activity level an...

Renal Involvement in Chronic Lymphocytic Leukemia: A Case Report

Chronic lymphocytic leukemia (CLL) is a neoplastic condition of B cells that frequently affects the lymph nodes, liver, spleen and bone marrow. The extranodal involvement of CLL is most commonly observed in the skin, whe...

Current Approach to Hyperbaric Oxygen Therapy

Hyperbaric oxygen (HBO) therapy is a therapy method based on inhalation of 100% pure oxygen through a mask or endotracheal tube or directly from the environment while subjected to a fully closed pressure chamber with >1...

Download PDF file
  • EP ID EP685082
  • DOI 10.4274/imj.galenos.2020.93753
  • Views 131
  • Downloads 0

How To Cite

Reyhan Sürmeli, Tülay Erden Habeşoğlu (2020). A New Treatment Option for Vestibular Migraine: Onabotulinum Toxin Type A. Istanbul Medical Journal, 21(3), -. https://europub.co.uk/articles/-A-685082